Rakuten Medical Partners With LOTTE Biologics to Expand Manufacturing for Alluminox® Photoimmunotherapy

  Rakuten Medical, Inc. and LOTTE Biologics announced that they have signed a biopharmaceutical contract manufacturing agreement during the J.P....

January 15, 2026 | Thursday | News
TetraScience and Thermo Fisher Scientific Partner to Accelerate Scientific AI Across Biopharma R&D and Manufacturing

   TetraScience, the Scientific Data and AI company,  announced a collaboration with Thermo Fisher Scientific Inc., the world leader in ser...

January 14, 2026 | Wednesday | News
Charles River to Acquire K.F. Cambodia and PathoQuest, Strengthening DSA Supply Chain and Expanding NAMs Capabilities

Signs Agreement to Acquire K.F. (Cambodia) Ltd. to Further Strengthen DSA Supply Chain; Transaction Expected to be Accretive to Non-GAAP Earnin...

January 13, 2026 | Tuesday | News
Enginzyme and AGC Present Scalable Manufacturing Process for Key mRNA Ingredient m¹ΨTP

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-met...

January 13, 2026 | Tuesday | News
Tensive Reports Positive Pivotal Trial Results for REGENERA™ in Lumpectomy Patients

Clinical data from pivotal trial in patients undergoing lumpectomy confirm strong safety profile and growing performance benefits Primary safety endp...

January 09, 2026 | Friday | News
CARsgen Submits Dual IND Applications in China for Allogeneic BCMA CAR-T CT0596 in Multiple Myeloma and Plasma Cell Leukemia

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that it has submi...

December 30, 2025 | Tuesday | News
Viva Biotech Showcases Integrated PK/PD Platform Across Small Molecules, Peptides, PROTACs, and Antibodies

Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and m...

December 30, 2025 | Tuesday | News
Caliway Submits FDA IND for Phase 2 Study of CBL-514 in Combination With Eli Lilly’s Zepbound® for Weight Management

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical...

December 26, 2025 | Friday | News
Pfizer Phase 3 BASIS Study Shows HYMPAVZI Delivers 93% Bleed Reduction in Hemophilia With Inhibitors

-Pfizer Inc. (NYSE: PFE) today presented results from the Phase 3 BASIS study (NCT03938792) evaluating HYMPAVZI® (marstacimab) for adults and adolesc...

December 08, 2025 | Monday | News
AstraZeneca Showcases Broad Advances in Blood Cancer and Rare Disease Care With 65 Presentations at ASH 2025

Investigational T-cell engager, surovatamig, and CAR T-cell therapy, AZD0120, will show potential with initial data across multiple blood cancers New ...

December 05, 2025 | Friday | News
AdvanCell Initiates TheraPb Phase 2 Expansion Evaluating 212Pb-ADVC001 Following Encouraging Phase 1b Data Presented at ESMO 2025

Clinical development of 212Pb-ADVC001 (ADVC001) is advancing rapidly with encouraging Phase 1b data presented at ESMO 2025 The Phase 2 expansion wil...

December 04, 2025 | Thursday | News
Philips Launches Verida CT, Setting a New Standard for AI-Driven Spectral Imaging

Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-revi...

December 02, 2025 | Tuesday | News
Cullinan’s FLT3-Targeted T Cell Engager CLN-049 Receives FDA Fast Track for R/R AML

Promising efficacy and favorable safety data from the Phase 1 study in heavily pre-treated patients show potential of CLN-049 to address a broad populati...

December 02, 2025 | Tuesday | News
HelixAI Launches Agentic OS Built for End-to-End R&D Automation, Backed by NVIDIA, AWS, and Sapio Sciences

New operating system enables scientists to move from copilot to autopilot, unifying diverse in silico, wet lab research and scientists to accelerate in...

November 19, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close